The World Health Organization unveiled a six-month plan to stamp out the ongoing Bundibugyo Ebola virus outbreak, including a scale-up of point-of-care molecular diagnostics. WHO said it will expand deployment of a point-of-care PCR system from South Korea-based KH Medical while strengthening reference lab capacity and sequencing-based surveillance. The plan calls for roughly $518 million in total investment, with Africa CDC, FIND, Unitaid, and local governments participating. WHO director-general Tedros Adhanom Ghebreyesus emphasized speed, coordination, and consistency as key lessons from prior Ebola responses. In parallel, Roche developed a research-use-only PCR test to detect the rare Bundibugyo strain to support response efforts amid limited diagnostic availability. Together, the initiatives underline how fast-track testing is becoming central to outbreak measurement and containment.